Epic Sciences epicsciences.com


Public list: Digital Health (6428) Genomics (614)

Epic Sciences is developing diagnostics to personalize and advance the treatment and management of cancer. Epic's mission is to enable the rapid and non-invasive detection of genetic and molecular changes in cancer throughout a patient's journey. The company was founded on a platform to identify and characterize rare cells, including CTCs. Its technology helps match patients to targeted therapies and monitor for drug resistance. Epic Sciences partners with pharmaceutical companies and major canc...Show all

Epic Sciences is developing diagnostics to personalize and advance the treatment and management of cancer. Epic's mission is to enable the rapid and non-invasive detection of genetic and molecular changes in cancer throughout a patient's journey. The...Show all

Company (Alive / Active)

Phone: 858-356-6610

Fax:

9381 Judicial Drive
Suite 200
San Diego, 92121
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Epic Sciences $147.5M Sep 12, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Epic Sciences Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Arcus VenturesVenture CapitalNew York, New York, United StatesSeries C
Deerfield ManagementVenture CapitalNew York, New York, United StatesSeries E
Blue Ox CapitalPrivate EquityNew York, New York, United StatesSeries E
Alexandria Venture InvestmentsCorporate VenturePasadena, California, United StatesSeries E
Altos Capital PartnersVenture CapitalUnited StatesSeries E, Series D
See all 21 investors
There is no Competitors data available for this company. Please select another tab.